tiprankstipranks
Trending News
More News >
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269
Hong Kong Market
Advertisement

Wuxi Biologics (Cayman) (2269) Ratios

Compare
51 Followers

Wuxi Biologics (Cayman) Ratios

HK:2269's free cash flow for Q2 2025 was ¥0.43. For the 2025 fiscal year, HK:2269's free cash flow was decreased by ¥ and operating cash flow was ¥0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.88 2.78 1.98 2.37 3.16
Quick Ratio
2.69 2.54 1.74 2.16 2.92
Cash Ratio
0.99 1.27 0.69 1.09 1.58
Solvency Ratio
0.50 0.36 0.39 0.34 0.25
Operating Cash Flow Ratio
0.67 0.61 0.59 0.42 0.42
Short-Term Operating Cash Flow Coverage
2.25 8.10 4.19 1.62 2.45
Net Current Asset Value
¥ 13.07B¥ 8.64B¥ 5.12B¥ 8.20B¥ 6.14B
Leverage Ratios
Debt-to-Assets Ratio
0.08 0.08 0.09 0.10 0.12
Debt-to-Equity Ratio
0.11 0.11 0.13 0.13 0.16
Debt-to-Capital Ratio
0.10 0.10 0.11 0.12 0.14
Long-Term Debt-to-Capital Ratio
<0.01 0.04 0.04 0.02 0.08
Financial Leverage Ratio
1.34 1.40 1.41 1.36 1.41
Debt Service Coverage Ratio
2.28 6.67 3.91 1.86 2.52
Interest Coverage Ratio
37.30 28.08 95.67 98.42 41.14
Debt to Market Cap
0.02 0.02 0.01 <0.01 <0.01
Interest Debt Per Share
1.24 1.13 1.08 0.98 0.80
Net Debt to EBITDA
-0.45 -0.93 -0.32 -1.04 -1.63
Profitability Margins
Gross Profit Margin
42.65%40.08%44.04%46.93%45.13%
EBIT Margin
29.40%25.43%35.51%39.19%35.79%
EBITDA Margin
36.93%32.30%40.76%43.87%41.19%
Operating Profit Margin
29.31%26.12%40.34%37.48%31.33%
Pretax Profit Margin
30.69%24.50%35.09%38.81%35.03%
Net Profit Margin
20.92%19.96%28.95%32.93%30.09%
Continuous Operations Profit Margin
24.54%20.96%29.80%34.10%30.16%
Net Income Per EBT
68.19%81.45%82.50%84.86%85.92%
EBT Per EBIT
104.69%93.79%86.99%103.53%111.81%
Return on Assets (ROA)
6.94%6.01%8.92%7.70%5.83%
Return on Equity (ROE)
9.67%8.43%12.61%10.50%8.21%
Return on Capital Employed (ROCE)
11.32%9.09%15.30%10.78%7.19%
Return on Invested Capital (ROIC)
8.56%7.66%12.54%8.92%5.99%
Return on Tangible Assets
7.18%6.23%9.31%8.09%5.95%
Earnings Yield
2.57%3.14%2.00%1.02%0.47%
Efficiency Ratios
Receivables Turnover
2.85 2.73 2.96 3.14 2.37
Payables Turnover
11.86 12.25 10.76 8.84 4.77
Inventory Turnover
6.95 5.78 3.75 3.24 2.84
Fixed Asset Turnover
0.66 0.57 0.59 0.52 0.44
Asset Turnover
0.33 0.30 0.31 0.23 0.19
Working Capital Turnover Ratio
1.30 1.50 1.50 0.98 0.68
Cash Conversion Cycle
149.68 167.23 186.81 187.59 206.11
Days of Sales Outstanding
127.92 133.88 123.31 116.10 154.17
Days of Inventory Outstanding
52.53 63.15 97.43 112.78 128.51
Days of Payables Outstanding
30.77 29.80 33.93 41.29 76.57
Operating Cycle
180.44 197.03 220.75 228.88 282.68
Cash Flow Ratios
Operating Cash Flow Per Share
1.35 1.12 1.33 0.78 0.45
Free Cash Flow Per Share
0.41 0.11 -0.08 -0.70 -0.98
CapEx Per Share
0.93 1.02 1.41 1.48 1.43
Free Cash Flow to Operating Cash Flow
0.31 0.09 -0.06 -0.90 -2.20
Dividend Paid and CapEx Coverage Ratio
1.44 1.10 0.94 0.53 0.31
Capital Expenditure Coverage Ratio
1.44 1.10 0.94 0.53 0.31
Operating Cash Flow Coverage Ratio
1.12 1.02 1.25 0.80 0.56
Operating Cash Flow to Sales Ratio
0.29 0.27 0.36 0.33 0.34
Free Cash Flow Yield
1.12%0.40%-0.15%-0.93%-1.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
38.88 31.85 49.89 97.89 213.87
Price-to-Sales (P/S) Ratio
7.81 6.36 14.44 32.23 64.36
Price-to-Book (P/B) Ratio
3.63 2.68 6.29 10.28 17.56
Price-to-Free Cash Flow (P/FCF) Ratio
88.99 247.65 -674.95 -107.28 -87.17
Price-to-Operating Cash Flow Ratio
28.51 23.20 39.79 96.67 192.00
Price-to-Earnings Growth (PEG) Ratio
1.37 -1.41 1.62 1.11 3.61
Price-to-Fair Value
3.63 2.68 6.29 10.28 17.56
Enterprise Value Multiple
20.69 18.75 35.12 72.44 154.63
Enterprise Value
153.22B 103.16B 218.55B 326.98B 357.44B
EV to EBITDA
20.69 18.75 35.12 72.44 154.63
EV to Sales
7.64 6.06 14.31 31.78 63.69
EV to Free Cash Flow
87.10 235.97 -668.91 -105.75 -86.26
EV to Operating Cash Flow
26.78 22.10 39.44 95.29 190.00
Tangible Book Value Per Share
11.11 10.08 8.18 6.95 4.83
Shareholders’ Equity Per Share
10.60 9.69 8.40 7.33 4.89
Tax and Other Ratios
Effective Tax Rate
0.20 0.14 0.15 0.12 0.14
Revenue Per Share
4.73 4.09 3.66 2.34 1.33
Net Income Per Share
0.99 0.82 1.06 0.77 0.40
Tax Burden
0.68 0.81 0.83 0.85 0.86
Interest Burden
1.04 0.96 0.99 0.99 0.98
Research & Development to Revenue
0.04 0.05 0.04 0.05 0.05
SG&A to Revenue
0.08 0.09 0.08 0.09 0.09
Stock-Based Compensation to Revenue
0.05 0.07 0.08 0.06 0.05
Income Quality
1.01 1.37 1.03 0.86 0.96
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis